GlobeNewsWire
03 Aug 2026, 10:34 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
ADMA Biologics is accused of a channel stuffing scheme to report 20% revenue growth in 2025 when actual growth was allegedly -3%. — Allegations of systemic financial manipulation and artificial revenue inflation are severe catalysts for valuation collapses and loss of investor trust.
-0.90A securities fraud class action lawsuit has been filed against ADMA Biologics and its senior executives in the U.S. District Court for the District of New Jersey. — Formal legal proceedings for fraud introduce significant litigation risk, potential settlement costs, and regulatory scrutiny.
-0.60Culper Research alleged that ADMA failed to disclose related party transactions involving a distributor. — Undisclosed related party transactions suggest poor corporate governance and potential conflicts of interest.
-0.50Continue reading
6 related stories
Search tags
Cantor downgraded ADMA Biologics' stock rating following the publication of the Culper Research short report. — Analyst downgrades typically trigger further institutional selling and downward pressure on the stock price.
-0.40Which stocks this story touches
The company is facing a class action lawsuit for securities fraud and allegations of channel stuffing.
Mentioned only as a historical reference for a legal recovery by the law firm.
Mentioned only as a historical reference for a legal recovery by the law firm.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
4h ago
